MetaCap

BioLineRx (BLRX) News

NASDAQ: BLRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.9639-0.0861 (-8.20%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BLRX news summary

We found 2 recent headlines mentioning BioLineRx (BLRX): 1 in the past week and 1 in the past 30 days, most often from Nasdaq. BLRX is making an outsized move today, down 8.20% at $0.9639, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "BioLineRx Ltd. and Hemispherian Present Phase 1/2a Clinical Study and Pre-Clinical Updates at SNO 2026", was published by Nasdaq on Nov 16, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest BioLineRx headlines

Stocks mentioned alongside BLRX

Compare BLRX